ACT | The App Association urges FDA to encourage use of apps in clinical trials
Today, ACT | The App Association urged the Food and Drug Administration to encourage the adoption of apps in clinical investigations. Mobile app-enabled telehealth and remote monitoring of patient generated health data (PGHD) is an incredibly promising avenue for improving healthcare quality while lowering costs. But, significant statutory and regulatory burdens [...]